Pulmicort and Reflux oesophagitis - a phase IV clinical study of FDA data

Summary:

Reflux oesophagitis is reported as a side effect among people who take Pulmicort (budesonide), especially for people who are male, 50-59 old, have been taking the drug for 6 - 12 months also take Singulair, and have Diarrhea.

The phase IV clinical study analyzes which people have Reflux oesophagitis when taking Pulmicort. It is created by eHealthMe based on reports of 34,552 people who have side effects when taking Pulmicort from the FDA, and is updated regularly.

What is Pulmicort?

Pulmicort has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 34,980 Pulmicort users. Check the latest studies of Pulmicort.

What is Reflux oesophagitis?

Reflux oesophagitis (an oesophageal mucosal injury that occurs of gastric contents into the oesophagus) is found to be associated with 338 drugs and 571 conditions by eHealthMe. Check the latest studies of Reflux oesophagitis.

On Aug, 08, 2026

34,552 people reported to have side effects when taking Pulmicort.
Among them, 14 people (0.04%) have Reflux oesophagitis.

Could Pulmicort cause Reflux oesophagitis?

Among these 14 people:

How long have people been on Pulmicort when they have Reflux oesophagitis? *

What is the gender of people who have Reflux oesophagitis when taking Pulmicort? *

female: 42.86 %
male: 57.14 %

What is the age of people who have Reflux oesophagitis when taking Pulmicort? *

What are other drugs people take besides Pulmicort? *

What are other side effects people have besides Reflux oesophagitis? *

Gastritis (inflammation of stomach): 5 people, 35.71%
Gallstones (stone formation by bile component): 4 people, 28.57%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 4 people, 28.57%
Gastritis Atrophic (process of chronic inflammation of the stomach mucosa): 4 people, 28.57%
Sinusitis (inflammation of sinus): 3 people, 21.43%
Croup Infectious (a loud cough that resembles the barking of a seal and difficulty breathing can transfer to other): 3 people, 21.43%
Pneumonia: 3 people, 21.43%
Conjunctivitis (pink eye): 3 people, 21.43%
Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose): 3 people, 21.43%
Diarrhea: 3 people, 21.43%

What are the existing conditions these people have? *

Upper Respiratory Tract Inflammation: 3 people, 21.43%
Tonsillitis (inflammation of tonsil): 3 people, 21.43%
Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose): 3 people, 21.43%
Pseudocroup (sudden laryngeal spasm with crowing inhalation and cyanosis, usually seen in children at night): 3 people, 21.43%
Pneumonia: 3 people, 21.43%
Otitis Media (inflammation of the middle ear): 3 people, 21.43%
Gastroenteritis (inflammation of stomach and intestine): 3 people, 21.43%
Fever: 3 people, 21.43%
Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon): 3 people, 21.43%
Diarrhea: 3 people, 21.43%

* Approximation only. Some reports may have incomplete information.

Do you take Pulmicort and have Reflux oesophagitis?

- Check whether Reflux oesophagitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pulmicort:

Pulmicort (34,980 reports)

Browse all side effects of Pulmicort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Reflux oesophagitis:

Reflux oesophagitis (338 drugs)

Browse all the conditions that are associated with Reflux oesophagitis:

Reflux oesophagitis (571 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on budesonide (the active ingredients of Pulmicort) and Pulmicort (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.